...
scph-img

Scpharmaceuticals Inc, Common Stock

SCPH

NSQ

$3.353

+$0.1

(3.08%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$162.63M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
177.45K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.14
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$3.08 L
$6.71 H
$3.353

About Scpharmaceuticals Inc, Common Stock

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. Its lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion due to fluid overload in adults with chronic heart failure and kidney disease, as well as consists of subcutaneous loop diuretic that delivers IV equivalent diuresis at home; and FUROSCIX On-Body Infusor, a drug-device combination product consisting of FUROSCIX. The company's product pipeline also includes SCP-111 (furosemide injection), an investigational pH neutral aqueous furosemide formulation that is being developed for subcutaneous administration outside of the hospital setting, including patient self-administration in the home; and SCP-111 Autoinjector, an investigational single-entity, drug-device combination product candidate consisting of a prefilled syringe containing SCP-111, preloaded into a commercially available, fixed single dose, disposable, two step mechanical autoinjector. It has a collaboration agreement with West Pharmaceutical Services, Inc. The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameSCPHSectorS&P500
1-Week Return-9.97%-3.39%0.2%
1-Month Return-2.99%-1.92%2.72%
3-Month Return-41.02%-10.54%7.31%
6-Month Return-20.15%-4.47%10.44%
1-Year Return-44.92%4.06%27.53%
3-Year Return-32.99%0.94%30.88%
5-Year Return-36.65%36.67%89.21%
10-Year Return-76.95%102.87%199.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue---2.06M13.59M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":15.18,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue364.00K399.00K438.00K468.00K3.81M[{"date":"2019-12-31","value":9.55,"profit":true},{"date":"2020-12-31","value":10.47,"profit":true},{"date":"2021-12-31","value":11.49,"profit":true},{"date":"2022-12-31","value":12.28,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(364.00K)(399.00K)(438.00K)(468.00K)9.78M[{"date":"2019-12-31","value":-3.72,"profit":false},{"date":"2020-12-31","value":-4.08,"profit":false},{"date":"2021-12-31","value":-4.48,"profit":false},{"date":"2022-12-31","value":-4.78,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin---(22.69%)71.96%[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-31.52,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses32.91M29.93M25.82M36.16M65.18M[{"date":"2019-12-31","value":50.48,"profit":true},{"date":"2020-12-31","value":45.93,"profit":true},{"date":"2021-12-31","value":39.62,"profit":true},{"date":"2022-12-31","value":55.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(32.91M)(29.93M)(25.82M)(36.16M)(55.40M)[{"date":"2019-12-31","value":-3290500000,"profit":false},{"date":"2020-12-31","value":-2993300000,"profit":false},{"date":"2021-12-31","value":-2582300000,"profit":false},{"date":"2022-12-31","value":-3615700000,"profit":false},{"date":"2023-12-31","value":-5539600000,"profit":false}]
Total Non-Operating Income/Expense(198.00K)(4.55M)(4.74M)(2.78M)(2.58M)[{"date":"2019-12-31","value":-19800000,"profit":false},{"date":"2020-12-31","value":-454800000,"profit":false},{"date":"2021-12-31","value":-473700000,"profit":false},{"date":"2022-12-31","value":-278000000,"profit":false},{"date":"2023-12-31","value":-257500000,"profit":false}]
Pre-Tax Income(33.00M)(32.21M)(28.03M)(36.84M)(54.81M)[{"date":"2019-12-31","value":-3299600000,"profit":false},{"date":"2020-12-31","value":-3220900000,"profit":false},{"date":"2021-12-31","value":-2803400000,"profit":false},{"date":"2022-12-31","value":-3683800000,"profit":false},{"date":"2023-12-31","value":-5481000000,"profit":false}]
Income Taxes1.42M2.18M2.45M681.00K458.11K[{"date":"2019-12-31","value":57.87,"profit":true},{"date":"2020-12-31","value":89.07,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":27.77,"profit":true},{"date":"2023-12-31","value":18.68,"profit":true}]
Income After Taxes(34.41M)(34.39M)(30.49M)(37.52M)(55.27M)[{"date":"2019-12-31","value":-3441500000,"profit":false},{"date":"2020-12-31","value":-3439300000,"profit":false},{"date":"2021-12-31","value":-3048600000,"profit":false},{"date":"2022-12-31","value":-3751900000,"profit":false},{"date":"2023-12-31","value":-5526810500,"profit":false}]
Income From Continuous Operations(33.00M)(32.21M)(28.03M)(36.84M)(50.25M)[{"date":"2019-12-31","value":-3299600000,"profit":false},{"date":"2020-12-31","value":-3220900000,"profit":false},{"date":"2021-12-31","value":-2803400000,"profit":false},{"date":"2022-12-31","value":-3683800000,"profit":false},{"date":"2023-12-31","value":-5024600000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(34.41M)(34.39M)(30.49M)(37.52M)(54.81M)[{"date":"2019-12-31","value":-3441500000,"profit":false},{"date":"2020-12-31","value":-3439300000,"profit":false},{"date":"2021-12-31","value":-3048600000,"profit":false},{"date":"2022-12-31","value":-3751900000,"profit":false},{"date":"2023-12-31","value":-5481000000,"profit":false}]
EPS (Diluted)(1.77)(1.32)(1.03)(1.30)(1.42)[{"date":"2019-12-31","value":-177,"profit":false},{"date":"2020-12-31","value":-132,"profit":false},{"date":"2021-12-31","value":-103,"profit":false},{"date":"2022-12-31","value":-130,"profit":false},{"date":"2023-12-31","value":-142,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

SCPH
Cash Ratio 5.99
Current Ratio 8.08
Quick Ratio 6.89

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SCPH
ROA (LTM) -42.02%
ROE (LTM) -166.89%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SCPH
Debt Ratio Lower is generally better. Negative is bad. 0.75
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.25

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SCPH
Trailing PE NM
Forward PE NM
P/S (TTM) 5.37
P/B 5.21
Price/FCF NM
EV/R 4.00
EV/Ebitda NM

FAQs

What is Scpharmaceuticals Inc share price today?

Scpharmaceuticals Inc (SCPH) share price today is $3.353

Can Indians buy Scpharmaceuticals Inc shares?

Yes, Indians can buy shares of Scpharmaceuticals Inc (SCPH) on Vested. To buy Scpharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SCPH stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Scpharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Scpharmaceuticals Inc (SCPH) via the Vested app. You can start investing in Scpharmaceuticals Inc (SCPH) with a minimum investment of $1.

How to invest in Scpharmaceuticals Inc shares from India?

You can invest in shares of Scpharmaceuticals Inc (SCPH) via Vested in three simple steps:

  • Click on Sign Up or Invest in SCPH stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Scpharmaceuticals Inc shares
What is Scpharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Scpharmaceuticals Inc (SCPH) is $6.71. The 52-week low price of Scpharmaceuticals Inc (SCPH) is $3.08.

What is Scpharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Scpharmaceuticals Inc (SCPH) is

What is Scpharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Scpharmaceuticals Inc (SCPH) is 5.21

What is Scpharmaceuticals Inc dividend yield?

The dividend yield of Scpharmaceuticals Inc (SCPH) is 0.00%

What is the Market Cap of Scpharmaceuticals Inc?

The market capitalization of Scpharmaceuticals Inc (SCPH) is $162.63M

What is Scpharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Scpharmaceuticals Inc is SCPH

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top